
Patrick D. Hawn
Examiner (ID: 11800)
| Most Active Art Unit | 3631 |
| Art Unit(s) | 4176, 3631, 3637 |
| Total Applications | 1048 |
| Issued Applications | 677 |
| Pending Applications | 58 |
| Abandoned Applications | 336 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19361112
[patent_doc_number] => 20240263146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => HUMAN NSCLC CELL LINES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/008443
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008443 | HUMAN NSCLC CELL LINES AND USES THEREOF | Jun 2, 2021 | Pending |
Array
(
[id] => 18485189
[patent_doc_number] => 20230212516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS FOR EXPANDING HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/000603
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000603
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000603 | METHODS FOR EXPANDING HEMATOPOIETIC STEM CELLS | Jun 1, 2021 | Pending |
Array
(
[id] => 18511668
[patent_doc_number] => 20230227848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/007677
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007677
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007677 | CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME | May 31, 2021 | Pending |
Array
(
[id] => 18530221
[patent_doc_number] => 20230235291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => SOMATIC STEM CELL-ACCUMULATED TISSUE CONSTRUCT AND DEVICE FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/010667
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010667 | SOMATIC STEM CELL-ACCUMULATED TISSUE CONSTRUCT AND DEVICE FOR PRODUCING THE SAME | May 27, 2021 | Pending |
Array
(
[id] => 18583130
[patent_doc_number] => 20230265389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHOD OF TRANSFECTING MACROPHAGES
[patent_app_type] => utility
[patent_app_number] => 17/927793
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927793 | METHOD OF TRANSFECTING MACROPHAGES | May 26, 2021 | Pending |
Array
(
[id] => 17243735
[patent_doc_number] => 20210363478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => DEVICE AND METHOD FOR THE EXTRACTION OF STEM CELLS FROM ADIPOSE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/325920
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 513
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325920 | DEVICE AND METHOD FOR THE EXTRACTION OF STEM CELLS FROM ADIPOSE TISSUE | May 19, 2021 | Abandoned |
Array
(
[id] => 17082108
[patent_doc_number] => 20210277114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CAR BASED IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/321629
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17321629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/321629 | Car based immunotherapy | May 16, 2021 | Issued |
Array
(
[id] => 18522966
[patent_doc_number] => 20230233617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHODS FOR DIFFERENTIATING STEM CELLS INTO DOPAMINERGIC PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/923265
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923265 | METHODS FOR DIFFERENTIATING STEM CELLS INTO DOPAMINERGIC PROGENITOR CELLS | May 6, 2021 | Pending |
Array
(
[id] => 18376253
[patent_doc_number] => 20230151336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => STEM CELL DERIVED SINGLE-ROSETTE BRAIN ORGANOIDS AND RELATED USES THEROF
[patent_app_type] => utility
[patent_app_number] => 17/920599
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920599 | STEM CELL DERIVED SINGLE-ROSETTE BRAIN ORGANOIDS AND RELATED USES THEROF | Apr 21, 2021 | Pending |
Array
(
[id] => 16963233
[patent_doc_number] => 20210214732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => LUX EXPRESSION IN CELLS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/210131
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210131 | LUX EXPRESSION IN CELLS AND METHODS OF USE | Mar 22, 2021 | Abandoned |
Array
(
[id] => 18530224
[patent_doc_number] => 20230235294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => HUMAN INDUCED PLURIPOTENT STEM CELL LINE TRANSFORMED WITH FLUORESCENT PROTEIN-LABELED CYTOCHROME P450 AND AHR MODULATOR SCREENING METHOD USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/010932
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010932
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010932 | HUMAN INDUCED PLURIPOTENT STEM CELL LINE TRANSFORMED WITH FLUORESCENT PROTEIN-LABELED CYTOCHROME P450 AND AHR MODULATOR SCREENING METHOD USING SAME | Mar 18, 2021 | Pending |
Array
(
[id] => 18296572
[patent_doc_number] => 20230106258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => NOVEL USE OF CROSS-FLOW FILTRATION DEVICE FOR PREPARING FUNCTIONAL EXOSOME
[patent_app_type] => utility
[patent_app_number] => 17/909939
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909939 | Use of cross-flow filtration device for preparing functional exosome | Mar 15, 2021 | Issued |
Array
(
[id] => 17183831
[patent_doc_number] => 20210330716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/184238
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184238 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Feb 23, 2021 | Abandoned |
Array
(
[id] => 18391692
[patent_doc_number] => 20230159910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => DIMETHYLMONOTHIOARSINIC ACID-INDUCED MALIGNANTLY TRANSFORMED CELL LINE OF HUMAN KERATINOCYTES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/631478
[patent_app_country] => US
[patent_app_date] => 2021-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631478 | DIMETHYLMONOTHIOARSINIC ACID-INDUCED MALIGNANTLY TRANSFORMED CELL LINE OF HUMAN KERATINOCYTES AND USE THEREOF | Feb 19, 2021 | Pending |
Array
(
[id] => 16916239
[patent_doc_number] => 20210189331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS OF EXPANDING EMBRYONIC STEM CELLS IN A SUSPENSION CULTURE
[patent_app_type] => utility
[patent_app_number] => 17/178279
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178279 | Methods of expanding embryonic stem cells in a suspension culture | Feb 17, 2021 | Issued |
Array
(
[id] => 17037144
[patent_doc_number] => 20210254102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Preparation Method for Attenuated Rhabdovirus and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 17/168311
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168311
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168311 | Preparation Method for Attenuated Rhabdovirus and Application Thereof | Feb 4, 2021 | Abandoned |
Array
(
[id] => 18229732
[patent_doc_number] => 20230068726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => TRANSPOSON SYSTEMS FOR GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 17/794166
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794166 | TRANSPOSON SYSTEMS FOR GENOME EDITING | Jan 27, 2021 | Pending |
Array
(
[id] => 16839796
[patent_doc_number] => 20210147808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHOD FOR PRODUCING INTESTINAL EPITHELIAL CELL AND INTESTINAL EPITHELIAL CELL
[patent_app_type] => utility
[patent_app_number] => 17/158797
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158797 | METHOD FOR PRODUCING INTESTINAL EPITHELIAL CELL AND INTESTINAL EPITHELIAL CELL | Jan 25, 2021 | Abandoned |
Array
(
[id] => 16946780
[patent_doc_number] => 20210205471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => CONCEPTS FOR THE TREATMENT OF GENETIC DISORDERS WITH HIGH-CAPACITY PLAL-GENERATED GOLD NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/155411
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155411 | CONCEPTS FOR THE TREATMENT OF GENETIC DISORDERS WITH HIGH-CAPACITY PLAL-GENERATED GOLD NANOPARTICLES | Jan 21, 2021 | Abandoned |
Array
(
[id] => 18344416
[patent_doc_number] => 20230132526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => USE OF EPHB4 AS A TARGET IN SCREENING DRUGS OR MODELS FOR INCREASING INSULIN SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 17/911953
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911953 | USE OF EPHB4 AS A TARGET IN SCREENING DRUGS OR MODELS FOR INCREASING INSULIN SENSITIVITY | Dec 29, 2020 | Pending |